BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Xiao EH, Guo D, Bian DJ. Effect of preoperative transcatheter arterial chemoembolization on angiogenesis of hepatocellular carcinoma cells. World J Gastroenterol 2009; 15(36): 4582-4586 [PMID: 19777619 DOI: 10.3748/wjg.15.4582]
URL: https://www.wjgnet.com/1007-9327/full/v15/i36/4582.htm
Number Citing Articles
1
Wen Chen, Tao Ma, Jian Zhang, Xiaozhen Zhang, Wei Chen, Yinan Shen, Xueli Bai, Tingbo Liang. A systematic review and meta-analysis of adjuvant transarterial chemoembolization after curative resection for patients with hepatocellular carcinomaHPB 2020; 22(6): 795 doi: 10.1016/j.hpb.2019.12.013
2
Joseph A Breuer, K Hamzah Ahmed, Fares Al-Khouja, Anvesh R Macherla, Jackline M Muthoka, Nadine Abi-Jaoudeh. Interventional oncology: new techniques and new devicesThe British Journal of Radiology 2022; 95(1138) doi: 10.1259/bjr.20211360
3
Lin Mu, Julius Chapiro, Jeremiah Stringam, Jean-François Geschwind. Interventional Oncology in Hepatocellular CarcinomaThe Cancer Journal 2016; 22(6): 365 doi: 10.1097/PPO.0000000000000227
4
E. Jubeli, N. Yagoubi, F. Pascale, L. Bédouet, K. Slimani, D. Labarre, J.P. Saint-Maurice, A. Laurent, L. Moine. Embolization biomaterial reinforced with nanotechnology for an in-situ release of anti-angiogenic agent in the treatment of hyper-vascularized tumors and arteriovenous malformationsEuropean Journal of Pharmaceutics and Biopharmaceutics 2015; 96: 396 doi: 10.1016/j.ejpb.2015.09.006
5
Marcelo Guimaraes, Renan Uflacker. Locoregional Therapy for Hepatocellular CarcinomaClinics in Liver Disease 2011; 15(2): 395 doi: 10.1016/j.cld.2011.03.013
6
Jianzhen Lin, Liangcai Wu, Xue Bai, Yuan Xie, Anqiang Wang, Haohai Zhang, Xiaobo Yang, Xueshuai Wan, Xin Lu, Xinting Sang, Haitao Zhao. Combination treatment including targeted therapy for advanced hepatocellular carcinomaOncotarget 2016; 7(43): 71036 doi: 10.18632/oncotarget.11954
7
James Ronald, Andrew B. Nixon, Daniele Marin, Rajan T. Gupta, Gemini Janas, Willa Chen, Paul V. Suhocki, Waleska Pabon-Ramos, David R. Sopko, Mark D. Starr, John C. Brady, Herbert I. Hurwitz, Charles Y. Kim. Pilot Evaluation of Angiogenesis Signaling Factor Response after Transcatheter Arterial Embolization for Hepatocellular CarcinomaRadiology 2017; 285(1): 311 doi: 10.1148/radiol.2017162555
8
Kenneth N. Huynh, Sriram Rao, Bradley Roth, Theodore Bryan, Dayantha M. Fernando, Farshid Dayyani, David Imagawa, Nadine Abi-Jaoudeh. Targeting Hypoxia-Inducible Factor-1α for the Management of Hepatocellular CarcinomaCancers 2023; 15(10): 2738 doi: 10.3390/cancers15102738
9
Huan Tong, Xiao Li, Chun Le Zhang, Jin Hang Gao, Shi Lei Wen, Zhi Yin Huang, Fu Qiang Wen, Ping Fu, Cheng Wei Tang. Transcatheter arterial embolization followed by octreotide and celecoxib synergistically prolongs survival of rabbits with hepatic VX2 allograftsJournal of Digestive Diseases 2013; 14(1): 29 doi: 10.1111/1751-2980.12001
10
Elisa Pinto, Filippo Pelizzaro, Fabio Farinati, Francesco Paolo Russo. Angiogenesis and Hepatocellular Carcinoma: From Molecular Mechanisms to Systemic TherapiesMedicina 2023; 59(6): 1115 doi: 10.3390/medicina59061115
11
Mohamed Bouattour, Hélène Marijon, Chantal Dreyer, Sandrine Faivre, Éric Raymond. Thérapies ciblées dans le carcinome hépatocellulaireLa Presse Médicale 2010; 39(7-8): 753 doi: 10.1016/j.lpm.2009.11.016
12
Riccardo Lencioni, Josep M. Llovet, Guohong Han, Won Young Tak, Jiamei Yang, Alfredo Guglielmi, Seung Woon Paik, Maria Reig, Do Young Kim, Gar-Yang Chau, Angelo Luca, Luis Ruiz del Arbol, Marie-Aude Leberre, Woody Niu, Kate Nicholson, Gerold Meinhardt, Jordi Bruix. Sorafenib or placebo plus TACE with doxorubicin-eluting beads for intermediate stage HCC: The SPACE trialJournal of Hepatology 2016; 64(5): 1090 doi: 10.1016/j.jhep.2016.01.012
13
Sebastian Buschauer, Andreas Koch, Philipp Wiggermann, Martina M�ller, Claus Hellerbrand. Hepatocellular carcinoma cells surviving doxorubicin treatment exhibit increased migratory potential and resistance to doxorubicin re-treatment in�vitroOncology Letters 2018;  doi: 10.3892/ol.2018.7887
14
Minoru Matsubara, Hidenori Shiraha, Jyunro Kataoka, Masaya Iwamuro, Shigeru Horiguchi, Shin‐ichi Nishina, Nobuyuki Takaoka, Masayuki Uemura, Akinobu Takaki, Shinichiro Nakamura, Yoshiyuki Kobayashi, Kazuhiro Nouso, Kazuhide Yamamoto. Des‐γ‐carboxyl prothrombin is associated with tumor angiogenesis in hepatocellular carcinomaJournal of Gastroenterology and Hepatology 2012; 27(10): 1602 doi: 10.1111/j.1440-1746.2012.07173.x
15
Yan Fu, Chu Hui Zeng, Chao An, Yue Liu, Ji Hoon Shin, Xiao Li. How Biology Guides the Combination of Locoregional Interventional Therapies and Immunotherapy for Hepatocellular Carcinoma: Cytokines and Their RolesCancers 2023; 15(4): 1324 doi: 10.3390/cancers15041324
16
C. Damiano Gadaleta, Girolamo Ranieri. Trans-arterial chemoembolization as a therapy for liver tumours: New clinical developments and suggestions for combination with angiogenesis inhibitorsCritical Reviews in Oncology/Hematology 2011; 80(1): 40 doi: 10.1016/j.critrevonc.2010.10.005
17
Osamu Matsui. Current Status of Hepatocellular Carcinoma Treatment in JapanClinical Drug Investigation 2012; 32(S2): 3 doi: 10.1007/BF03265492
18
Nadine Abi-Jaoudeh, Ben Sadeghi, Hanna Javan, Jim Na, Graham Beaton, Fabio Tucci, Satheesh Ravula, David K. Imagawa. Drug-Eluting Embolic Loaded with Tyrosine Kinase Inhibitor Targeted Therapies for Transarterial Chemoembolization in a VX2 ModelCancers 2023; 15(12): 3236 doi: 10.3390/cancers15123236
19
Xiang Cheng, Ping Sun, Qing-Gang Hu, Zi-Fang Song, Jun Xiong, Qi-Chang Zheng. Transarterial (chemo)embolization for curative resection of hepatocellular carcinoma: a systematic review and meta-analysesJournal of Cancer Research and Clinical Oncology 2014; 140(7): 1159 doi: 10.1007/s00432-014-1677-4
20
Qin Shi, Tongqiang Li, Songjiang Huang, Yaowei Bai, Yingliang Wang, Jiacheng Liu, Chen Zhou, Yang Chen, Bin Xiong. Transcatheter Arterial Embolization Containing Donafenib Induces Anti-Angiogenesis and Tumoricidal CD8+ T-Cell Infiltration in Rabbit VX2 Liver TumorCancer Management and Research 2021; : 6943 doi: 10.2147/CMAR.S328294
21
Alexander Gross, Thomas Albrecht. Transarterial Chemoembolisation (TACE) with Degradable Starch Microspheres (DSM) and Anthracycline in Patients with Locally Extensive Hepatocellular Carcinoma (HCC): Safety and EfficacyCardioVascular and Interventional Radiology 2020; 43(3): 402 doi: 10.1007/s00270-019-02364-w
22
Mario Petrillo, Francesca Patella, Filippo Pesapane, Matteo B Suter, Anna M Ierardi, Salvatore A Angileri, Chiara Floridi, Massimo de Filippo, Gianpaolo Carrafiello. Hypoxia and tumor angiogenesis in the era of hepatocellular carcinoma transarterial loco-regional treatmentsFuture Oncology 2018; 14(28): 2957 doi: 10.2217/fon-2017-0739
23
Chen Zhou, Qi Yao, Hongsen Zhang, Xiaopeng Guo, Jiacheng Liu, Qin Shi, Songjiang Huang, Bin Xiong. Combining transcatheter arterial embolization with iodized oil containing Apatinib inhibits HCC growth and metastasisScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-59746-1
24
Nadine Abi-Jaoudeh, Farshid Dayyani, Pei Jer Chen, Dayantha Fernando, Nicholas Fidelman, Hanna Javan, Po-Chin Liang, Jen-I Hwang, David K Imagawa. Phase I Trial on Arterial Embolization with Hypoxia Activated Tirapazamine for Unresectable Hepatocellular CarcinomaJournal of Hepatocellular Carcinoma 2021; : 421 doi: 10.2147/JHC.S304275
25
Jiang Li, Fan Yang, Jian Li, Zhi-Yong Huang, Qi Cheng, Er-Lei Zhang. Postoperative adjuvant therapy for hepatocellular carcinoma with microvascular invasionWorld Journal of Gastrointestinal Surgery 2023; 15(1): 19-31 doi: 10.4240/wjgs.v15.i1.19
26
Iliana Doycheva, Paul J. Thuluvath. Systemic Therapy for Advanced Hepatocellular Carcinoma: An Update of a Rapidly Evolving FieldJournal of Clinical and Experimental Hepatology 2019; 9(5): 588 doi: 10.1016/j.jceh.2019.07.012
27
Yanming Zhou, Xiaofeng Zhang, Lupeng Wu, Feng Ye, Xu Su, Lehua Shi, Bin Li. Meta-analysis: preoperative transcatheter arterial chemoembolization does not improve prognosis of patients with resectable hepatocellular carcinomaBMC Gastroenterology 2013; 13(1) doi: 10.1186/1471-230X-13-51
28
Osamu Matsui. Current Status of Hepatocellular Carcinoma Treatment in JapanClinical Drug Investigation 2012; 32: 3 doi: 10.2165/1163021-S0-000000000-00000
29
Manon Buijs, Diane K. Reyes, Timothy M. Pawlik, Amanda L. Blackford, Riad Salem, Wells A. Messersmith, Colin D. Weekes, Mary Mulcahy, Ihab R. Kamel, Jean‐Francois H. Geschwind. Phase 2 trial of concurrent bevacizumab and transhepatic arterial chemoembolization in patients with unresectable hepatocellular carcinomaCancer 2013; 119(5): 1042 doi: 10.1002/cncr.27859
30
Chen Zhou, Qin Shi, Jiacheng Liu, Songjiang Huang, Chongtu Yang, Bin Xiong. Effect of Inhibiting Tumor Angiogenesis After Embolization in the Treatment of HCC with Apatinib-Loaded p(N-Isopropyl-Acrylamide-co-Butyl Methyl Acrylate) Temperature-Sensitive NanogelJournal of Hepatocellular Carcinoma 2020; : 447 doi: 10.2147/JHC.S282209